Seminar. Getting it Right Early.
Where drug, device and patient experience meet the science and strategy of moving from vial to drug-device combination product.
PRESENTATIONS 12PM-4:30PM. RECEPTION 4:30-6:00PM.
Join us on this knowledge sharing seminar, designed for biopharma companies developing injectable therapies considering the transition from vials to prefilled syringes (PFS) and ultimately to integrated drug–device combination (DDC) products.
Early choices. Lasting impact.
As injectable drug products advance through clinical trials, development teams face increasingly complex decisions that shape long-term commercial success. Choices surrounding formulation, container systems, devices, testing, and packaging often made during clinical development can significantly impact scalability, regulatory readiness, patient usability, and overall risk.
Through expert-led sessions and interactive discussion, attendees will gain practical guidance on how to future-proof their programs and confidently plan for commercialization.
Future-proof your program
Supported by industry-leading device platform providers, container and packaging specialists, and ISO-compliant testing experts, this seminar brings together the technical disciplines required to successfully bridge the clinical to commercial gap.
- New Brunswick, NJ - March 3, 2026
- Cambridge, MA - March 5, 2026
- San Francisco, CA - March 10, 2026
- San Diego, CA - March 12, 2026
12pm-4:30pm for presentations. Reception 4:30-6:00pm.
- Hilton East Brunswick - New Jersey
- Royal Sonesta Hotel - Cambridge, MA
- Embassy Suites - San Francisco Airport
- Marriott San Diego - LaJolla
Join us and benefit from...
Learn what it truly takes to move beyond the vial from formulation and process development considerations and container closure interactions to device functionality, human factors, and lifecycle management.
Understand how patient needs, usability, ergonomics, and sustainability influence device and packaging design, and how early decisions impact scalability and compliance.
Gain clarity on key ISO standards and testing strategies that support process validation, batch release, and regulatory submissions for combination products.
Explore integrated manufacturing, assembly, packaging, and tech transfer approaches that reduce cost, time, and development risk as programs scale.
Engage face-to-face with experienced subject matter experts, ask program-specific questions, and learn from organizations supporting today’s leading drug–device platforms.
Learn how structured technical governance helps manage dependencies, mitigate risk, and maintain momentum across SFF, device assembly, packaging, and supply chain execution.
Our seminar partners
Learn more about our sterile capabilities that deliver quality, innovation, and reliability from development through commercialization.
Contact us today and talk to our expert customer services team about how we can support you with sterile drug development services.
Inspired by tomorrow, and with over 8000 people in 38 global GMP facilities, we support you from early-stage development through commercialization and beyond.